Kings Global Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 1.81 Cr
- Company Age 8 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 14.32 Cr
- Satisfied Charges ₹ 4.81 Cr
- Revenue Growth 38.73%
- Profit Growth 10.09%
- Ebitda 24.41%
- Net Worth 15.99%
- Total Assets 143.71%
About Kings Global Biotech
Kings Global Biotech Limited (KGBL) is a Public Limited Indian Non-Government Company incorporated in India on 09 June 2016 (Eight years and eight months 25 days old ). Its registered office is in Pune, Maharashtra, India.
The Corporate was formerly known as Kings Global Biotech Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.81 Cr.
The company currently has active open charges totaling ₹14.32 Cr. The company has closed loans amounting to ₹4.81 Cr, as per Ministry of Corporate Affairs (MCA) records.
Girish Jaiwal, Manodnya Sapre, and Kartiki Tupe serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U33119PN2016PLC164905
- Company No.
164905
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
09 Jun 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Pharma
What products or services does Kings Global Biotech Limited offer?
Kings Global Biotech Limited offers a wide range of products and services, including TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Anti Infective Drugs & Medicines, Anti Infective Agent, Cardiovascular Drugs & Medication, Blood Pressure Medicine, Antibiotic Tablets, Capsule & Syrup, Anticoagulant and Antiplatelet Drugs.
Who are the key members and board of directors at Kings Global Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Girish Jaiwal  | Director | 09-Jun-2016 | Current |
| Manodnya Sapre | Whole-Time Director | 14-Mar-2020 | Current |
| Kartiki Tupe | Additional Director | 28-Sep-2022 | Current |
Financial Performance of Kings Global Biotech.
Kings Global Biotech Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 38.73% increase. The company also saw a substantial improvement in profitability, with a 10.09% increase in profit. The company's net worth Soared by an impressive increase of 15.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kings Global Biotech?
In 2021, Kings Global Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Skp Global Medicines Private LimitedGirish Jaiwal and Manodnya Sapre are mutual person
Venturecorp Consultans Pvt LtdManodnya Sapre is a mutual person
Charges (Loans)
Open Charges
₹14.32 Cr
Satisfied Charges
₹4.81 Cr
Charges Breakdown by Lending Institutions
- Yes Bank Limited : 14.32 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Mar 2021 | Yes Bank Limited | ₹14.32 Cr | Open |
| 26 Mar 2019 | The South Indian Bank Limited | ₹4.81 Cr | Satisfied |
How Many Employees Work at Kings Global Biotech?
Unlock and access historical data on people associated with Kings Global Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kings Global Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kings Global Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Kings Global Biotech
Recent activity within the organization
- Annual General Meeting
Kings Global Biotech Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
- Balance Sheet
Kings Global Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Pune.
- Director Appointment
Kartiki Ramesh Tupe was appointed as a Additional Director was appointed as a Additional Director on 28 Sep 2022 & has been associated with this company since 2 years 5 months .
- Charges
A charge registered on 26 Mar 2019 via Charge ID 100254389 with The South Indian Bank Limited was fully satisfied on 04 Jan 2022.
- Charges
A charge with Yes Bank Limited of Rs. 14.32 Cr registered on 25 Mar 2021 with Charge ID 100436116 was modified on 31 Dec 2021.
- Charges
A charge with Yes Bank Limited amounted to Rs. 14.32 Cr with Charge ID 100436116 was registered on 25 Mar 2021.
Frequently asked questions
What is the Incorporation or founding date of Kings Global Biotech Limited?
Kings Global Biotech Limited was incorporated on 09 Jun 2016.
What is authorized share capital and paid-up capital of Kings Global Biotech Limited?
The authorized share capital of Kings Global Biotech Limited is ₹ 2.00 Cr and paid-up capital is ₹ 1.81 Cr.
Who are the current board members & directors of Kings Global Biotech Limited?
Currently 3 directors are associated with Kings Global Biotech Limited.
- Girish Bhimrao Jaiwal
- Manodnya Shashank Sapre
- Kartiki Ramesh Tupe
What is the registered address of Kings Global Biotech Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Kings Global Biotech Limited is Mittal Chambers J.M.Road, Shivajinagar India, Pune, Maharashtra, 411030.
What is the corporate identification number (CIN) and company number of Kings Global Biotech Limited?
The corporate identification number (CIN) of Kings Global Biotech Limited is U33119PN2016PLC164905 and the company number is 164905 as per Ministry of Corporate Affairs (MCA).
What is the official website of Kings Global Biotech Limited?
The Official website of Kings Global Biotech Limited is https://www.kingsglobalbiotech.com
What has been the recent revenue trend for Kings Global Biotech Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for Kings Global Biotech Limited has risen by 38.73%.
What change has been observed in the net worth of Kings Global Biotech Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Kings Global Biotech Limited has experienced an upsurge of 15.99%.
What are the total open charges for Kings Global Biotech Limited?
As per the financial statements for fiscal Year 2022, The total open charges for Kings Global Biotech Limited amount to ₹ 14.32 Cr.
When was the last Balance Sheet of Kings Global Biotech Limited filed with the ROC?
The most recent Balance Sheet for Kings Global Biotech Limited was filed with the ROC on 31 Mar 2023.
People also Viewed
VN
Vaibhav NagarkarAdditional DirectorBJ
Bhimrao JaiwalDirectorGJ
Gangubai JaiwalDirector
Similar Companies Based on Drug Formulation & Development
Mylan Laboratories Limited Hyderabad, Telangana, India
Sun Pharma Laboratories Limited Mumbai, Maharashtra, India
Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
Lupin Limited Mumbai, Maharashtra, India
Alkem Laboratories Limited Mumbai, Maharashtra, India
Hetero Labs Limited Rangareddy, Telangana, India
Aurobindo Pharma Ltd Hyderabad, Telangana, India
Cipla Limited Mumbai, Maharashtra, India